Clinical and Molecular Hepatology

"Ying Wang"

Letters to the Editor

Correspondence to editorial on “Dysfunction in CD8+ T Cells in Early-Stage HCC” by Qin et al.: New Insights into HCC Immunotherapy: Yang Kong, Xiaoqian Shen, Kun Xue, Haiying Wang; Received August 4, 2025 Accepted August 22, 2025 Published online September 1, 2025; DOI: https://doi.org/10.3350/cmh.2025.0880 [Accepted]

MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”: Ying Wang, Shengfeng Wang, Xiude Fan, Jiajun Zhao, Yongfeng Song; Clin Mol Hepatol 2025;31(2):e128-e133.
Published online December 26, 2024; DOI: https://doi.org/10.3350/cmh.2024.1008

Citations

Citations to this article as recorded by

Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Xin Qiu, Shuang Shen, Nizhen Jiang, Yifei Feng, Guodong Yang, Donghong Lu
BMC Gastroenterology.2025;[Epub] CrossRef
Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
Seogsong Jeong, Won Kim, Sang Min Park
Clinical and Molecular Hepatology.2025; 31(2): e210. CrossRef